iLCT Pipeline Research Acceleration Programme

Every year this programme will call for expressions of interest and subsequent applications for funding based on specified project outlines developed by Cure Parkinson’s from the iLCT committee feedback. This may be to test one or more therapies that has been evaluated by iLCT but requires further research before moving into clinical trial. These project outlines will include details such as:

• The therapy (or therapies) to be tested
• The type of models to be used
• Any specific assessments to be included
• Max project cost
• Max project duration (typically 6 -18 months)

Expressions of interest received will be reviewed internally to ensure they meet the project criteria before applicants are invited to work with Cure Parkinson’s to submit a full application. For more information on expressions of interest, please read ‘How to apply for funding’ below. Full applications will then be sent for external expert peer review, including at least one reviewer from the iLCT committee. Considering the peer reviews of each application, the Cure Parkinson’s independent research committee will evaluate the applications and make a funding recommendation to Cure Parkinson’s trustees. For further information about this funding programme, please email research@cureparkinsons.org.uk.

The 2025 iLCT Pipeline Research Acceleration Programme funding round is now open. Please see the project outline for more information. If you have any questions, please email research@cureparkinson.org.uk.

To be considered for funding, please fill in the expression of interest form. These will be reviewed anonymously internally at Cure Parkinson’s on a rolling basis and will be used to invite full applications for those projects most closely aligned with the goals of the funding call.

Please note, only full applications that have been invited for submission will be sent out to external peer review and further considered for funding by our independent research committee.